Detailed Mechanism Funding and Narrative

Years of mechanism: 2011 2012 2013 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 12692
Country/Region: Haiti
Year: 2017
Main Partner: Ministre de la Sante Publique et Population - Haiti
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $14,882,542 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $637,665
Care: Orphans and Vulnerable Children (HKID) $1,296,688
Care: TB/HIV (HVTB) $582,098
Care: Pediatric Care and Support (PDCS) $180,127
Laboratory Infrastructure (HLAB) $1,214,201
Strategic Information (HVSI) $1,743,109
Health Systems Strengthening (OHSS) $1,349,800
Testing: HIV Testing and Counseling (HVCT) $1,822,745
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $980,091
Treatment: Adult Treatment (HTXS) $4,874,169
Treatment: Pediatric Treatment (PDTX) $201,849
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2018 287
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2018 85
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2018 778
GEND_GBV Number of people receiving post-GBV care 2018 863
GEND_GBV Unknown Age, Female, Sexual Violence (Post-Rape Care) 2018 1
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 211,396
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Female, Negative 2018 5,848
HTS_TST Service Delivery Point Agg Age (Facility) Index: 15+, Male, Negative 2018 3,898
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Female, Negative 2018 108
HTS_TST Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Male, Negative 2018 72
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Negative 2018 33
HTS_TST Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Negative 2018 23
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 20,906
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 13,959
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Negative 2018 961
HTS_TST Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Negative 2018 641
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Negative 2018 20,266
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Negative 2018 13,512
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Negative 2018 37,686
HTS_TST Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Negative 2018 25,125
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Negative 2018 113
HTS_TST Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Negative 2018 76
HTS_TST Sum of Test Result disaggregates 2018 5,362
HTS_TST_POS By Test Result: Positive 2018 5,362
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Female, Positive 2018 449
HTS_TST_POS Service Delivery Point Agg Age (Facility) Index: 15+, Male, Positive 2018 299
HTS_TST_POS Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age (Community) Homebased testing: 15+, Male, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Female, Positive 2018 2
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Inpatient: 15+, Male, Positive 2018 1
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 471
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 313
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Female, Positive 2018 87
HTS_TST_POS Service Delivery Point by Agg Age (Facility) TB: 15+, Male, Positive 2018 57
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Female, Positive 2018 212
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: <15, Male, Positive 2018 141
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,205
HTS_TST_POS Service Delivery Point by Agg Age (Facility) VCT: 15+, Male, Positive 2018 802
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Female, Positive 2018 3
HTS_TST_POS Service Delivery Point by Agg Age(Community) Mobile Testing: 15+, Male, Positive 2018 2
OVC_SERV Age/Sex: <1 2018 499
OVC_SERV Age/Sex: 1-9 2018 1,989
OVC_SERV Age/Sex: 10-14 Female 2018 1,640
OVC_SERV Age/Sex: 10-14 Male 2018 1,093
OVC_SERV Age/Sex: 15-17 Female 2018 1,192
OVC_SERV Age/Sex: 15-17 Male 2018 795
OVC_SERV By: Age/sex: 18-24 Female 2018 894
OVC_SERV By: Age/sex: 25+ Female 2018 2,235
OVC_SERV By: Age/sex: Male 18-24 2018 598
OVC_SERV By: Age/sex: Male 25+ 2018 1,493
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2018 12,430
OVC_SERV Program Completion: Active 2018 9,656
OVC_SERV Program Completion: Exited without graduation 2018 368
OVC_SERV Program Completion: Graduation 2018 364
OVC_SERV Program Completion: Transferred 2018 2,042
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2018 17
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 25+ 2018 371
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2018 11
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 25+ 2018 248
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2018 210
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2018 75
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 25+ 2018 246
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 25+ 2018 110
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2018 275
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2018 177
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2018 17
OVC_SERV Sum of Age/Sex disaggregates 2018 4,720
PMTCT_ART Already on ART at beginning of current pregnancy 2018 516
PMTCT_ART New on ART 2018 699
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 1,215
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 67,970
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 1,211
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 537
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 645
PMTCT_EID Number of infants with a positive virological test result between 2 and 12 months of birth 2018 18
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2018 11
PMTCT_STAT By Age (Numerator): Unknown Age 2018 1,275
PMTCT_STAT By Number of known positives: Unknown Age 2018 587
PMTCT_STAT By Number of new negative: Unknown Age 2018 66,695
PMTCT_STAT By Number of new positives: Unknown Age 2018 683
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 67,970
PMTCT_STAT_den By Age (Denominator): Unknown Age 2018 70,068
PP_PREV Age/sex: 10-14 Female 2018 738
PP_PREV Age/sex: 15-19 Female 2018 537
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2018 1,275
PP_PREV Sum of Age/Sex disaggregates 2018 1,275
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 8
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 177
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 3
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 128
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 316
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 316
TB_ART_den Aggregated Age/Sex: Female <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 8
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 175
TB_ART_den Aggregated Age/Sex: Male <15 (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 3
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 130
TB_PREV By Age/Sex (Numerator): <15, Female 2018 119
TB_PREV By Age/Sex (Numerator): <15, Male 2018 82
TB_PREV By Age/Sex (Numerator): 15+, Female 2018 2,396
TB_PREV By Age/Sex (Numerator): 15+, Male 2018 1,400
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2018 4,001
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2018 4,440
TB_PREV_den By Age/Sex (Denominator): <15, Female 2018 133
TB_PREV_den By Age/Sex (Denominator): <15, Male 2018 89
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2018 2,663
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2018 1,554
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 78
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,517
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 53
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,013
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,661
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 2,844
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 82
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,620
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 55
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,087
TX_CURR Aggregated Age/Sex: <15 Female 2018 729
TX_CURR Aggregated Age/Sex: <15 Male 2018 485
TX_CURR Aggregated Age/Sex: 15+ Female 2018 14,020
TX_CURR Aggregated Age/Sex: 15+ Male 2018 9,347
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 24,585
TX_CURR Sum of Aggregated Age/Sex <15 2018 1,214
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 23,367
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 24,581
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 162
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 159
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 2,817
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 2,047
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 5,188
TX_NEW Pregnancy status 2018 697
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 5,185
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 24,587
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 18,441
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 500
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 54
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 333
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 36
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 9,953
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,106
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 5,807
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 646
TX_PVLS Numerator: Indication: Routine 2018 16,594
TX_PVLS Numerator: Indication: Targeted 2018 1,847
TX_PVLS Numerator: Preg/BF by Indication: Pregnant Routine 2018 928
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 663
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2018 72
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 443
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2018 48
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 13,271
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2018 1,476
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 7,745
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2018 863
TX_PVLS_den Denominator: Indication: Routine 2018 22,124
TX_PVLS_den Denominator: Indication: Targeted 2018 2,459
TX_PVLS_den Denominator: Preg/BF by Indication: Pregnant Routine 2018 928
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 91
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 64
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,960
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 1,246
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 3,361
TX_RET Numerator by Status: Pregnant 2018 478
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 4,441
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 134
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 89
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 2,661
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 1,555
TX_RET_den Denominator by Status: Pregnant 2018 478
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2018 22,602
TX_TB Number of ART patients who were started on TB treatment during the reporting period 2018 452
TX_TB Numerator: By Aggregated Age/Sex: <15, Female 2018 6
TX_TB Numerator: By Aggregated Age/Sex: <15, Male 2018 10
TX_TB Numerator: By Aggregated Age/Sex: 15+, Female 2018 273
TX_TB Numerator: By Aggregated Age/Sex: 15+, Male 2018 163
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2018 678
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2018 452
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2018 13,558
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2018 7,912
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2018 2,258
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2018 2,260
TX_TB_den Denominator: By Screen Result: Negative 2018 22,147
TX_TB_den Denominator: By Screen Result: Positive 2018 452
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2018 4,520
Cross Cutting Budget Categories and Known Amounts Total: $3,075,000
Key Populations: MSM and TG $500,000
Training of health workers and community outreach workers
Collection and use of strategic information
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $500,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Monitoring and evaluation of SW programs
Gender: Gender Based Violence (GBV) $750,000
GBV Prevention
Capacity building
Monitoring and Evaluation
Post GBV Care
Gender: Gender Equality $450,000
Promoting gender-related policies and laws that increase legal protection
Changing harmful gender norms and promoting positive gender norms
Capacity building
Monitoring and Evaluation
Human Resources for Health $500,000
Construction $135,000
Motor Vehicles: Purchased $240,000